Sp Group A/S

Hi and good afternoon. On behalf of Hans Christian Andersen Capital, I would like to welcome you all to this presentation of the report of the first quarter of 24 from SP Group that was published yesterday. My name is Rasmus Koiper and I have the pleasure of welcoming CEO of SP Group, that's Frank Gell. And we also have CFO Tille Kainoff with us today. They promised to take us through the quarterly numbers and the highlights. So a warm welcome to you.

Thank you very much and thank you for joining us. We have had a good beginning of the new year. We have increased the top line. We have got a better product mix, so we have sold more of our proprietary products and that has helped us to achieve a higher EBITDA and a better bottom line. We have also created a strong cash flow from the operation and we have increased the equity and we have reduced our net interest bank debt. Tilde, will you take us through the figures?

Yes. Maybe before I switch slides, I can also say that if you have any questions, you're welcome to send them through the chat during the presentation here and I will publish them as we go along. I might take some of the questions during the presentation or otherwise we'll take them when we finalize. But I can switch the slides here to first the management group. Then we have like a SB Group in brief. I think we'll skip those ones and then jump to the highlights of the Q1 2024. Yes.

In Q1, we increased the revenue by 2.2% to 723. Revenue from all brands increased with 25% to 205 millions. We increased the EBITDA by 16.2% to almost 150 millions. And due to a good product mix, including all brands, we increased the EBITDA margin by 2.4% to 20.5%. Profit before tax increased by almost 24% to 85 millions. Earnings per share also increased 24% to 5.47. End of March net bearing debt fell by 84 millions to 946 millions. The equity increased by 72 millions to 1.5 billions. And here you see some products from Dandel. And if you take the next one. Here you can see an overview over the last seven years. It has been an increase in almost all figures, but in 23, we had a decrease in the revenue in EBIT and profit before taxed.

And we believe that is because most of our customers have been destocking. So they have been bringing down the inventory level from a very high level, which they built up during the COVID period, where it was difficult to get stuff. And we think we have that behind us now. So now we are ready for growth again, and we have now had two quarters with growth.

Luckily, the equity increased by almost 200 million, and we had a nice cashflow from abrasion on 360 millions. And if you go to the next one, here, the revenues increase are shown during the years. We have an average increase on 10%, but in the year 14 to 17, we increased by 16%. We acquired the companies, Ohlstrøm Plast, Veliko Park, Lexopiro, and Even Compensate. In 2023, we had a small dip in the revenue on 2.2%. And luckily, in Q1, we increased the revenue again by 2.2%. The EBITDA have increased during the years and ended up in a level on 450 million. We decreased in 2023. That is also due to the product mix. And in Q1, we increased by 16%. And the next one shows the development in the FDM market. We have gone from 11% to around 10% and increased during the years. So we're up to 18%. Due to the mix, we fell to 17 in 2023 and now again up to almost 18. If you go to the next one, the profit before tax has increased during the year. We had some dip during what's called the exchange rate or But due to the high interest rate to the depreciation, we had a big decrease in 23. Luckily, we in Q1 got up to with an increase on 23%. And the next one shows the gearing. We was on a level on 7, went down to a 4% in gearing during the years, and then we dropped to 2. And we have gone on that level. In 2019, we got all the EFS 16 debt on the balance sheet. End of 2023, we was on 2.3. And then we, in Q1, are on 2. you go to the next one. Here's a short summary of the result in Q1. We had a growth in revenue on 2.2%, the EBITDA had an increase on 16%, the EBIT on 26%, profit before tax increased from 68 millions to almost 85, increase on 24% and the equity also increased by 15% We had a nice cash flow operation on 121 millions. We invested 30 millions and spent around 84 millions on debt. The debt was almost 950 and we had equity ratio on 50.

And you can see we have reduced the debt with 84 million from the beginning of the year. and we have increased the equity with almost 200 million in the last 12 months.

Good. Let's look at your revenue from Own Brands then.

Own Brands set this economics, it's housing, animal housing, ventilation and guide wires, medical packaging and standard components. In Q1, we had like 28.6% of the revenue was Own Brands. And that is an increase compared to 2023. The split by product area, we have a steady revenue in cleantech. We ended up with a revenue on 214 in Q1. We have a nice increase in the revenue of health care products ended up in two hundred sixty seventy eight eighty six and a decrease in the other domestic industry and food related industries. You can see in Q1, we had an increase of 22% in healthcare. After 23, there was a small decrease. Cleantech is up by 3.2%. After in 23, had an increase in 8%. Food related is down and automotive is also down, but automotive is on a relatively small revenue. Other demanding industries are also down. So it's a bit up and down in the industries. Home brands is 25% up and in 2023 it was 12% down.

So we are back in the first quarter to the high level we had in 2021 on home brands and that is helping us on the profitability and on the margins.

Good, let's look at the revenue here by the by the customer group.

40% of the sales came from healthcare and that is medical devices and economics, 30% from cleantech and 12% from food related industries and automotive is now down to 3% of sales. It is not cars, but it is vans and anything on wheel. So it's also buses, trains, bicycle trailers, and many other nice things. And then all the other industries are 15%. And the largest customer during 23 accounted for 12.6% of sales. And the 10 largest accounts for 46% of the sales. And the 20 largest customers account for 56%. And that is a little bit, you can say, it diluted compared to the year before on the top 10 and the top 20 despite the number one customer was growing rapidly during 23 and we are not publishing these figures on a quarterly basis so the figures here are from the full 12 months period during 23. And the global footprint from here? The global footprint from here is that we are soon going to Atlanta, to the United States, to take over a new factory. We're currently building and we expect that the building will be completed in June. And then we will start to put machines in and then we will start production in the second half of this year. and then we have maintained our global platform and global footprint as you can see it here so we have a factory in iowa and the factory in cleveland in ohio in the united states and then we open a new one that making injection molding and also clean room injection molding. And then in Asia, we are in tension in China and in suture in China with retroforming, rotational molding, polyurethane and injection molding. And we are in Thailand, in Bangkok, and then we are in Europe with manufacturing in Finland, in Latvia, in Sweden, in Denmark, in Poland, in Slovakia. And then we have sales offices in Sweden, Norway and the Netherlands and in Canada. And in total, we are 2350 committed colleagues. And the blue figures here shows how much we are selling in each region in the world. So 14% of the sales last year was invoice to customers in North and South America, 8% in Asia Pacific, 49% in Europe, and 29% to customers in Denmark. And during the first quarter, we were growing with 10% internationally, and we had a decrease to the sales to Danish customers. And I think that is mainly related to that In Denmark, we have almost one week off due to the Easter. And this year, the Easter is in the first quarter. Last year, the Easter was affecting our figures in the second quarter.

Very good. And let's have a look at sort of the acquisitions in the past. You haven't added that much here this year.

We've been drinking a lot of coffee, but we have not added any new companies during the 23 and 24 so far. But we have, during the last decade, acquired a number of companies, and that is good companies with a strong management team, exciting technologies, fantastic customers, and that has helped us to get a more global footprint and get many new technologies into the group we can offer to our other customers. Therefore we have been able to increase the cross-selling and that has all helped us to increase the margin. And as Tilde pointed out earlier on, we have moved from an EBITDA margin around 10% 10 years ago to now actually 20% in the first quarter this year. But if you take on the full year then we are between 17 and 18 on a 12 points rolling but the last quarter is 20 in market and that's uh pretty good we think compared to what we've been able to do in the past

Very good. And perhaps you should take one of the questions here in relation to the M&A strategy. There's a question here that goes, can you talk about your M&A strategy in light of the net interest bearing debt to EBITDA now nearing the low end of the target range, as we saw on one of the previous slides? Is the number of dialogues with potential targets increasing? So basically, are you drinking more coffee? at the moment than you have done in the past.

We are drinking more coffee now than we did in most part of 23. Most part of 23, I think people were pretty unrealistic about the prices on companies. We have seen our own company go 50% down in value from end of 21 to end of March in 24. So we have decreased with 50%. So the conclusion is we have not been able to buy new companies which we like to buy at reasonable prices. We have a strong balance sheet so we can do it. We have also noticed that the interest level is higher now than it was back in 21 and 20 and the years before where we acquired these companies basically in an environment where the interest rate was zero. Now the interest rate is higher. We hope the interest rate will come down again. And we also hope that we can find good companies to buy. And in the meantime, we are busy repaying debt to the banks. And we have repaid 85 million in the first quarter and take the gain down from 2.3 to 2.0. And we will soon, if we don't buy anything, then we will soon be lower than two, despite we have paid dividend during April this year.

And also on the valuation, the question goes here, have they become more realistic on valuation, the sellers, or what has perhaps been the obstacles, if any, sort of in the past?

Each case has its own story, but hopefully people will become more realistic.

Okay, good. And the last one here is if you're not able to make acquisitions, would you expect higher share buybacks or dividends?

Yes, but we will prefer to take the debt down because we are not happy paying all this money in interest charges to the banks as we are paying right now. So we are looking at the share buyback if we cannot find new acquisition candidates at reasonable prices. But we will look on this quarter by quarter.

Good. Let's jump one slide ahead here on the internationalization.

Here you can see we have been increasing the sales internationally in the first quarter of this year and therefore the shares decreased in Denmark. So the international sales is now 74% and I hope we can reach 75% during the year. We will open a new factory in the US and that will help us not a lot this year, but in the years to come. So the aim is to become more international and we have 70% of the Colleagues outside Denmark, we have now 17 factories around the world, and we're going to open one more this year, and that will take us to 18 by the end. And then this is without acquisitions, and we are not planning to close down any factories. So I expect that we will add the new factory in Atlanta and then keep what we have and try to improve the utilization of our current assets.

Very good. And then a couple of slides on the share price performance and the shareholders afterwards.

The share price has been developing very nice during a 10-year period from 2010 to the end of 21, actually 11 years. And then it has been a nightmare from during 22, 23 and the first quarter of 24. Now we hope that when we get top line growing again and DPI growing again and bottom line growing again, that people will get more confidence to the share price. Very good. And looking at the shareholders here? Yes, we have seen the number of shareholders increase over the years and actually during the difficult time in 2023, we got almost 1000 new shareholders. In the first four months of this year, we have lost some of them again so there are 100 people or so who has who has left us but we've got more shareholders international and we have now more than 100 shareholders who are not living in denmark and the international shareholders owns approximately one third of the shares the management team owns approximately one third of the shares, and all the other Danish investors own the last third of the shares. And among the largest shareholders, we have Lannebo in Sweden, Odin in Norway, and ATP in Denmark. And our largest shareholder is our chairman, Hans Schur, and his family and the company, Schur Finance. And I'm the second largest shareholder. And the management team has bought more shares during the open windows in the last year. Good.

And market conditions?

Market conditions are tough. Customers want better and cheaper products, and we help them to get that. So we help them to get rid of wood and metal and glass and substitute with plastic and composite. We manufacture globally with a powerful team, the right equipment and the right technology. And so we will open up injection molding in Atlanta so we can give local service in North America to our customers there. customers focus on the core business and outsource plastic production to specialists and we are happy to take over the production and use our skills and our scale to give them a better products lower capex lower opex delivery on time high quality and customers want fewer and better suppliers and it is our ambition to be the preferred supplier so when they cut down from 300 suppliers to 100 suppliers then it is important for us to be among the 100 they continue doing business with. And then we are focusing on industries with strong growth. And we believe that is healthcare, clean tech and the food industries. And they account for approximately three quarters of our total sales. The structural growth comes from we are getting a bigger and bigger population. We have a longer life. We want a better life. We want a healthier life. We want to get rid of pain or prevent we get pain. And to do all that, you need our advanced products. Same in cleantech to do the green transition and in the food industry to get better and healthier food and less waste of food.

Very good. And then the outlook. But maybe a question first when we have this picture, because there was actually a question coming up. Let me just find it here. What kind of product solutions are you offering within the cleantech industry and how are customers characterized? Are they large or small customers?

They are large and they are small. Some are global, some are local. We produce products in reaction injection molding, in injection molding, in blow molding, in rotational molding, in extrusion for the clean tech industries. And what do we mean by cleantech? Cleantech is renewable energy. It is clean water. It is clean air. It is meters that measure how much energy and water you consume. It is insulation. And it is devices that help you to reduce the consumption of energy.

Okay, very good. But let's have a look then on expectations for the rest of 2020.

There is no growth in Europe, very little growth. But most of the estimates we see now talk about zero growth in Europe this year. And we have a war going on in Ukraine and in Gaza, and there's still a lot of volatility in Europe. various areas of the market despite that we hope that we can grow the top line somewhere between five and fifteen percent and in the first quarter we only saw 2.8 percent organic growth and the currencies was a bit against us so it was 2.2 percent of the top line you can see in danish corner we believe that the growth will accelerate so we can get into this range during the year with an APTA margin between 16 and 19. And here we got a good start. So we're actually a little bit about the range here in the first quarter and the bottom line between 9 and 12. And here we are in the very high end of the range also. So we have maintained our guidance for the year and we still believe this is realistic.

Very good. There's a few slides here on sustainability, CSR, ESG. Do you have a few things to add there? We have a couple of minutes.

As we mentioned in our annual report, we got the municipality's approval of the local plan to establish a new solar park in Julesminne together with two partners. Unfortunately, there have been citizens who are objecting against this approval. So at the moment, the whole project is on ice. We hope that soon we can get back on track with that one. And then we have We got 82% of our electricity last year was green electricity, and we expect it will be more this year. And our aim is to go to 100% green electricity before 2030. And part of that we produce ourselves, and that will be a bigger and bigger portion over the years. So now we have solar panels in Slovakia, in Poland, in Finland, and soon we will also have it in Denmark.

Very good. But let's take a few last questions before we conclude for today. There was one here on the US factory. Will the new factory in the US provide some tax benefits, i.e. will your clients avoid any import tax with the local production facility?

I think that is two different things. We will not enjoy any tax benefits and we have not received any subsidy and we have not applied for any subsidy. I think import duties into the US are low between Europe and the US, but it can change in the future. And what we can offer people is that they get a lower CO2 footprint when they are going to use our products in the US. So instead of producing in Europe and shipping it to the US or producing it in Asia and shipping it to the US, we can produce locally.

Very good. And then there was a question that came in very early, and I think you addressed it somehow on the different slides. But could you perhaps give us a little bit more flavor on what is driving the EBITDA improvement? There are three drivers here.

A better top line. 25% increase in sales of home products and then we have adjusted the cost base so we are 100 people fewer than we were first quarter last year. That are the three main drivers. What is in the pipeline? In the pipeline is that we have never been as busy as we are right now with new projects for our customers. So there's a lot of innovation and there's a lot of development work going on. And that is, I think, also moving the top line and the APDA going forward.

Very good. And then a last question and perhaps we should move back to because I think it relates to sort of this slides with your different customer groups here, because the question goes here that where do you sort of see the best opportunities further into 2024 with the current start of the year?

In all the red boxes. also an automotive yes yes yes yes yes at the moment it is um it is very low but but it will pick up again this is this is not a structural crisis it is a temporary crisis and it is a small number for us luckily And we are not in diesel cars or add blue solutions to diesel cars and other stuff that will become obsolete. People will still need vans, they will still need construction equipment, tractors, harvesting machines, bicycle trailers, and trains and buses and all the other stuff we make on wheels.

Very good. And momentum seems very good in healthcare at the moment. Perhaps you could also add a little bit to that.

Momentum in healthcare is driven by a number of things. Innovation, new products, but also that we are getting a bigger and bigger population and we're getting older and older and we all wonder to have all our pain and all our other issues solved in the hospital or by the doctors. And then there's a lot of focus on, you can say, the economical aspects to prevent damages on your body. So people invest again now in economic solutions to make safe workplaces for the employees. And that's good. And in the long run, it is a good payback case for the companies and for society.

Very good. We will conclude by that. Thank you very much to all of those of you listening in. And thank you very much to you, Frank and Tilde, for the presentation here today. Thank you.

And thank you for joining. And thank you for all the good questions. Have a nice day.

Same from here. Thank you. Bye. Bye.